Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma

RNA interference (RNAi) treatment has been proven to be an important therapeutic approach in cancer based on downregulation of target-oncogenes, but its clinical efficacy still needs further investigation. LMP1 is usually presented by Epstein-Barr virus (EBV)-positive tumor cells like EBV-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Qi, Chen, Bing-Hong, Huang, Dai-jia, Zhang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361645/
https://www.ncbi.nlm.nih.gov/pubmed/37493769
http://dx.doi.org/10.1590/1414-431X2023e12638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361645/
https://www.ncbi.nlm.nih.gov/pubmed/37493769
http://dx.doi.org/10.1590/1414-431X2023e12638

Ejemplares similares